Front Pediatr 8:535705 Hassapidou M, Duncanson K, Shrewsbury V et al (2023) EASO and EFAD position statement on medical nutrition therapy for the management of overweight and obesity in children and adolescents
Your provider may also evaluate for other contributing factors such as vitamin deficiencies (particularly B12, especially if you also take metformin, or iron, vitamin D), thyroid dysfunction, or medication interactions that could be addressed independently of semaglutide therapy
She combines her deep knowledge of GLP-1 medicationsincluding Zepbound , Wegovy , Ozempic , and Mounjaro with a warm, supportive coaching style
CrossRef Hepatoprotective effects of the branched-chain fatty acids 12-methylmyristic and 13-methylmyristic against palmitate-induced lipotoxicity Sara Rico-Chazarra, Carmen Garca-Melgares, Inmaculada Ros-Madrid, Mara A